Clinical Trials Logo

PCV clinical trials

View clinical trials related to PCV.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01884597 Completed - Clinical trials for Polypoidal Choroidal Vasculopathy

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)

PEARL2
Start date: November 2010
Phase: Phase 1/Phase 2
Study type: Interventional

This is a 24-month study of ranibizumab (2.0 mg and 1.0 mg) in subjects with polypoidal choroidal vasculopathy as diagnosed by fluorescein/indocyanine green (FA/ICG) angiography.